B. Alcaide, P. Almendros et al.
PdII-catalyzed oxybromination of b-allenols 1—Preparation of dihydro-
pyrans 11: Palladium(II) acetate (0.01 mmol), lithium bromide
(0.74 mmol), potassium carbonate (0.18 mmol), and copper(II) acetate
(0.32 mmol) were sequentially added to a stirred solution of the corre-
sponding b-allenol 1 (57 mg, 0.15 mmol) in acetonitrile (5 mL). The re-
sulting suspension was stirred at room temperature under an oxygen at-
mosphere for 2 h. The organic phase was diluted with brine (2 mL), ex-
tracted with ethyl acetate (3ꢅ5 mL), washed with brine (2 mL), dried
(MgSO4), and concentrated under reduced pressure. After flash chroma-
tography of the residue on silica gel eluting with a hexanes/ethyl acetate
(9:1) mixture, analytically pure compound 11 (10 mg, 10%) was obtained
as a colorless oil. [a]D =+21.9 (c=0.6 in CHCl3); 1H NMR (300 MHz,
CDCl3, 258C): d=7.95 and 6.93 (d, J=9.0 Hz, each 2H), 7.73 (m, 5H),
7.41 (m, 5H), 5.73 (m, 1H), 4.28 (dd, J=4.1, 2.0 Hz, 2H), 3.89 (s, 3H),
3.84 (m, 3H), 1.80 (brs, 3H), 1.08 ppm (s, 9H); IR (CHCl3): n˜ =
1725 cmꢀ1; MS (ES): m/z (%): 596 (100) [M+2+H]+, 594 (98) [M+H]+;
elemental analysis calcd (%) for C31H35BrO5Si (595.6): C 62.51, H 5.92;
found: C 62.63, H 5.96.
AuIII-catalyzed cyclization of g-allenol (ꢀ)-2—Preparation of tetrahy-
drooxepine (+)-13: AuCl3 (2.5 mg, 0.008 mmol) was added to a stirred
solution of the g-allenol (ꢀ)-2 (50 mg, 0.16 mmol) in dichloromethane
(160 mL) under argon. The resulting mixture was stirred at room temper-
ature for 3 h. The reaction was then quenched with brine (160 mL), the
mixture was extracted with ethyl acetate (3ꢅ1 mL), and the combined
extracts were washed twice with brine. The organic layer was dried
(MgSO4) and concentrated under reduced pressure. After flash chroma-
tography of the residue on silica gel eluting with a hexanes/ethyl acetate
(3:1) mixture, analytically pure compound 13 (34 mg, 67%) was obtained
as a colorless oil. [a]D =+5.4 (c=1.9 in CHCl3); 1H NMR (300 MHz,
CDCl3, 258C): d=8.05 and 6.93 (d, J=9.0 Hz, each 2H), 5.63 (m, 1H),
5.44 (m, 1H), 4.89 (m, 1H), 4.64 (m, 2H), 4.37 (m, 2H), 3.87 (s, 3H),
2.01 (s, 3H), 1.85 ppm (brs, 3H); 13C NMR (75 MHz, CDCl3, 258C): d=
170.8, 165.7, 163.6, 134.7, 131.9, 123.0, 122.3, 113.6, 87.3, 75.5, 73.1, 62.2,
55.4, 21.1, 12.7 ppm; IR (CHCl3): n˜ =1744, 1725 cmꢀ1; MS (ES): m/z (%):
321 (100) [M+H]+, 320 (9) [M]+; elemental analysis calcd (%) for
C17H20O6 (320.3): C 63.74, H 6.29; found: C 63.62, H 6.23.
PtII-catalyzed cyclization of g-allenol (ꢀ)-2—Preparation of tetrahy-
General procedure for the PdII-catalyzed coupling reaction of b-allenols
drooxepine (+)-14: [PtCl2ACHTNUGTRNE(GNU CH2=CH2)]2 (0.0015 mmol) was added to a
1
with allyl bromide—Preparation of dihydropyrans 12: PdCl2
stirred solution of the g-allenol (ꢀ)-2 (48 mg, 0.15 mmol) in dichlorome-
thane (150 mL) under argon. The resulting mixture was stirred at room
temperature for 2 h. The reaction was then quenched with brine
(150 mL), the mixture was extracted with ethyl acetate (3ꢅ1 mL), and the
combined extracts were washed twice with brine. The organic layer was
dried (MgSO4) and concentrated under reduced pressure. After flash
chromatography of the residue on silica gel eluting with a hexanes/ethyl
acetate (4:1) mixture, analytically pure compound 14 (37 mg, 77%) was
obtained as a colorless oil. [a]D =+6.2 (c=0.5 in CHCl3); 1H NMR
(300 MHz, CDCl3, 258C): d=8.02 and 6.94 (d, J=9.0 Hz, each 2H), 5.63
(m, 1H), 6.27 (m, 1H), 5.33 (dt, J=6.3, 2.9 Hz, 1H), 4.92 (t, J=2.7 Hz,
1H), 4.43 (m, 3H), 3.88 (s, 3H), 2.95 (m, 1H), 2.05 (s, 3H), 1.15 ppm (d,
J=6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3, 258C): d=165.5, 163.6,
163.5, 144.5, 131.7, 122.1, 113.7, 105.9, 86.1, 72.5, 62.6, 55.5, 39.6,
20.7 ppm; IR (CHCl3): n˜ =1742, 1722 cmꢀ1; MS (ES): m/z (%): 321 (100)
[M+H]+, 320 (3) [M]+; elemental analysis calcd (%) for C17H20O6
(320.3): C 63.74, H 6.29; found: C 63.87, H 6.35.
PdII-catalyzed coupling reaction of g-allenol (ꢀ)-2 with allyl bromide—
Preparation of tetrahydrooxepine (+)-15: PdCl2 (0.0075 mmol) was
added to a stirred solution of the g-allenol (ꢀ)-2 (48 mg, 0.15 mmol) and
allyl bromide (0.75 mmol) in N,N-dimethylformamide (0.9 mL). The reac-
tion was stirred under argon for 2 h. Water (0.8 mL) was added before
being extracted with ethyl acetate (3ꢅ5 mL). The organic phase was
washed with water (2ꢅ2 mL), dried (MgSO4), and concentrated under
reduced pressure. After flash chromatography of the residue on silica gel
eluting with a hexanes/ethyl acetate (7:1) mixture, analytically pure com-
pound 15 (30 mg, 56%) was obtained as a colorless oil. [a]D =+23.9 (c=
0.8 in CHCl3); 1H NMR (300 MHz, CDCl3, 258C): d=8.05 and 6.93 (d,
J=9.0 Hz, each 2H), 5.73 (m, 1H), 5.44 (m, 1H), 5.06 (m, 1H), 4.96 (m,
1H), 4.58 (m, 2H), 4.35 (m, 2H), 3.87 (s, 3H), 2.85 (t, J=5.5 Hz, 2H),
2.01 (s, 3H), 1.75 ppm (brs, 3H); 13C NMR (75 MHz, CDCl3, 258C): d=
169.6, 166.2, 165.6, 134.1, 132.6, 131.6, 122.3, 116.3, 113.8, 113.6, 89.0,
73.4, 73.0, 62.2, 55.4, 39.1, 29.4, 20.7 ppm; IR (CHCl3): n˜ =1744,
1724 cmꢀ1; MS (ES): m/z (%): 361 (100) [M+H]+, 360 (9) [M]+; elemen-
tal analysis calcd (%) for C20H24O6 (360.4): C 66.65, H 6.71; found: C
66.78, H 6.77.
(0.005 mmol) was added to a stirred solution of the corresponding b-alle-
nol 1 (0.10 mmol) and allyl bromide (0.50 mmol) in N,N-dimethylforma-
mide (0.6 mL). The reaction was stirred under an argon atmosphere until
disappearance of the starting material (TLC). Water (0.5 mL) was added
before being extracted with ethyl acetate (3ꢅ4 mL). The organic phase
was washed with water (2ꢅ2 mL), dried (MgSO4), and concentrated
under reduced pressure. Chromatography of the residue eluting with hex-
anes/ethyl acetate mixtures gave analytically pure dihydropyrans 12.
Dihydropyran (+)-12a: From b-allenol (ꢀ)-1a (50 mg, 0.13 mmol), and
after chromatography of the residue using hexanes/ethyl acetate (3:1) as
eluent, compound (+)-12a (58 mg, 80%) was obtained as a colorless oil.
[a]D =+18.4 (c=2.5 in CHCl3); 1H NMR (300 MHz, CDCl3, 258C): d=
7.96 and 6.92 (d, J=9.0 Hz, each 2H), 7.68 (m, 5H), 7.36 (m, 5H), 5.72
(m, 1H), 5.56 (m, 1H), 5.09 (dd, J=9.0, 1.6 Hz, 1H), 5.01 (m, 1H), 4.08
(m, 2H), 3.89 (s, 3H), 3.79 (m, 3H), 2.74 (m, 2H), 1.63 (brs, 3H),
1.08 ppm (s, 9H); 13C NMR (75 MHz, CDCl3, 258C): d=166.1, 157.0,
135.6, 135.2, 134.8, 134.2, 133.4, 131.8, 129.6, 129.5, 127.7, 127.5, 125.2,
121.2, 115.9, 113.6, 76.9, 68.7, 66.9, 63.9, 55.5, 33.3, 26.6, 26.5, 19.0 ppm;
IR (CHCl3): n˜ =1744 cmꢀ1; MS (ES): m/z (%): 557 (100) [M+H]+, 556
(7) [M]+; elemental analysis calcd (%) for C34H40O5Si (556.8): C 73.35, H
7.24; found: C 73.48, H 7.18.
Preparation of dihydropyrans (+)-12b and (ꢀ)-12c: From b-allenol (+)-
1b (75 mg, 0.16 mmol), and after chromatography of the residue using
hexanes/ethyl acetate (8:1) as eluent, 25 mg (32%) of the less polar com-
pound (+)-12b and 19 mg (31%) of the more polar compound (ꢀ)-12c
were obtained.
Dihydropyran (+)-12b: [a]D =+15.7 (c=1.1 in CHCl3); 1H NMR
(300 MHz, CDCl3, 258C): d=7.78 and 6.82 (d, J=9.0 Hz, each 2H), 7.20
(m, 5H), 5.80 (m, 1H), 5.67 (m, 1H), 5.07 (m, 1H), 5.00 (m, 1H), 4.32
(d, J=2.2 Hz, 1H), 4.28 (d, J=1.7 Hz, 1H), 3.90 (m, 3H), 3.83 (s, 3H),
2.69 (d, J=6.1 Hz, 2H), 0.89 (s, 9H), 0.08 and 0.05 ppm (s, each 3H);
13C NMR (75 MHz, CDCl3, 258C): d=165.5, 163.2, 137.3, 135.4, 135.1,
131.8, 131.5, 128.9, 128.0, 127.1, 122.4, 116.5, 113.4, 78.1, 68.0, 66.8, 63.6,
55.3, 34.6, 25.9, 18.4, ꢀ5.2, ꢀ5.3 ppm; IR (CHCl3): n˜ =1743 cmꢀ1; MS
(ES): m/z (%): 495 (100) [M+H]+, 494 (9) [M]+; elemental analysis
calcd (%) for C29H38O5Si (494.3): C 70.41, H 7.74; found: C 70.28, H
7.81.
Dihydropyran (ꢀ)-12c: [a]D =ꢀ10.3 (c=0.4 in CHCl3); 1H NMR
(300 MHz, CDCl3, 258C): d=7.69 and 6.81 (d, J=9.0 Hz, each 2H), 7.22
(m, 5H), 5.93 (m, 1H), 5.69 (m, 1H), 5.08 (m, 1H), 5.01 (m, 1H), 4.41
(dd, J=16.3, 2.6 Hz, 1H), 4.27 (dd, J=16.4, 2.0 Hz, 1H), 3.83 (m, 3H),
3.82 (s, 3H), 2.72 ppm (d, J=7.1 Hz, 2H); 13C NMR (75 MHz, CDCl3,
258C): d=163.5, 160.3, 136.8, 134.9, 134.8, 131.8, 131.6, 128.7, 128.1,
127.2, 121.8, 116.6, 113.7, 113.5, 77.4, 67.7, 67.5, 62.3, 55.4, 34.5 ppm; IR
(CHCl3): n˜ =3432, 1743 cmꢀ1; MS (ES): m/z (%): 381 (100) [M+H]+, 380
(17) [M]+; elemental analysis calcd (%) for C23H24O5 (380.4): C 72.61, H
6.36; found: C 72.74, H 6.31.
PdII-catalyzed oxybromination of g-allenol (ꢀ)-2—Preparation of tetra-
hydrooxepine (+)-16: Palladium(II) acetate (0.01 mmol), lithium bro-
mide (0.74 mmol), potassium carbonate (0.18 mmol), and copper(II) ace-
tate (0.32 mmol) were sequentially added to a stirred solution of the g-al-
lenol (ꢀ)-2 (48 mg, 0.15 mmol) in acetonitrile (5 mL). The resulting sus-
pension was stirred at room temperature under an oxygen atmosphere
for 9 h. The organic phase was diluted with brine (2 mL), extracted with
ethyl acetate (3ꢅ5 mL), washed with brine (2 mL), dried (MgSO4), and
concentrated under reduced pressure. After flash chromatography of the
residue on silica gel eluting with a hexanes/ethyl acetate (3:1) mixture,
analytically pure compound 16 (31 mg, 51%) was obtained as a colorless
oil. [a]D =+1.3 (c=1.2 in CHCl3); 1H NMR (300 MHz, CDCl3, 258C):
9136
ꢂ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2009, 15, 9127 – 9138